Recent Developments in Neurobiology of Obsessive-Compulsive Disorder
J Clin Psychiatry 1996;57(10):492-503
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Exciting new developments in the neurobiology of obsessive-compulsive disorder (OCD) and related disorders have emerged in the past few years, said Michael A. Jenike, M.D., chairperson of the symposium. The combination of advanced neuroimaging techniques along with collaboration between clinicians and researchers has contributed to greater understanding of the clinical implications as they relate to biological issues, he said. Dr. Jenike and fellow symposium presenters gathered to discuss the latest findings in neuroimaging, neuropsychology, and pharmacology and designed the conference to address the neurobiological and clinical implications of OCD, rather than the comprehensive treatment modalities for this disorder.